© 2020 MJH Life Sciences and OncLive. All rights reserved.
May 05, 2020
Clara Hwang, MD, discusses the phase 3 ERA-223 trial evaluating the addition of radium-223 dichloride to abiraterone acetate and prednisone in patients with metastatic castration-resistant prostate cancer and bone metastases.
April 24, 2020
Clara Hwang, MD, discusses the utility of docetaxel and abiraterone acetate in metastatic castration-sensitive prostate cancer.
April 14, 2020
Clara Hwang, MD, discusses the utility of antiandrogens in patients with metastatic prostate cancer.
February 07, 2020
Clara Hwang, MD, discusses the evolution of treatment for men with metastatic castration-sensitive prostate cancer.